Crossmark

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

Crossref DOI link: https://doi.org/10.1186/s12968-018-0478-3

Published Online: 2018-08-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ridouani, Fourat http://orcid.org/0000-0003-2582-464X
Damy, Thibaud

Tacher, Vania

Derbel, Haytham

Legou, François

Sifaoui, Islem

Audureau, Etienne

Bodez, Diane

Rahmouni, Alain

Deux, Jean-François
Funding

Funding for this research was provided by:

ARIM
License Information

Text and Data Mining valid from 2018-08-16
More Information

Article History

Received: 29 December 2017

Accepted: 19 July 2018

First Online: 16 August 2018

Ethics approval and consent to participate

: Our local ethics committee (Hôpital Henri-Mondor) approved the research and consent was obtained for all our patients.

: A written informed consent for publication was obtained from all the participant in the study.

: Author(s) declare(s) that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.